Biokarpet Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	213.15	205.49	209.99	231.22	187.29
Revenue Growth (YoY)	3.73%	-2.15%	-9.18%	23.46%	51.97%
Cost of Revenue	179.22	174.13	174.48	189.6	155.81
Gross Profit	33.93	31.37	35.51	41.63	31.48
Selling, General & Admin	27.6	27.83	27.5	27.95	23.62
Research & Development	0.76	0.62	0.58	0.5	0.58
Other Operating Expenses	-2.89	-2.43	-0.95	-0.28	-0.42
Operating Expenses	25.48	26.02	27.14	28.16	23.77
Operating Income	8.45	5.35	8.38	13.47	7.7
Interest Expense	-4.95	-6.67	-6.75	-3.89	-3.12
Interest & Investment Income	0.01	0	0	0	0.01
Currency Exchange Gain (Loss)	-0.06	-0.02	0.02	0.1	0
Other Non Operating Income (Expenses)	0.54	0.83	0.12	-0.1	-0.36
EBT Excluding Unusual Items	3.99	-0.51	1.77	9.57	4.23
Gain (Loss) on Sale of Investments	-0.12	0.05	0.05	-0	-0.03
Gain (Loss) on Sale of Assets	0.28	-0.56	-0.27	1.27	0.82
Pretax Income	4.15	1.08	6.28	10.84	5.02
Income Tax Expense	0.88	0.77	0.69	1.7	0.76
Earnings From Continuing Operations	3.27	0.31	5.58	9.13	4.26
Minority Interest in Earnings	-0.04	-0.01	-0.09	-0.14	-0.06
Net Income	3.23	0.3	5.49	8.99	4.21
Net Income to Common	3.23	0.3	5.49	8.99	4.21
Net Income Growth	968.55%	-94.49%	-38.94%	113.87%	1971.19%
Shares Outstanding (Basic)	24	24	24	24	24
Shares Outstanding (Diluted)	24	24	24	24	24
EPS (Basic)	0.13	0.01	0.23	0.37	0.18
EPS (Diluted)	0.13	0.01	0.23	0.37	0.18
EPS Growth	968.57%	-94.49%	-38.94%	113.87%	1971.30%
Free Cash Flow	-10.03	-4.7	-0.66	-5.74	-3.26
Free Cash Flow Per Share	-0.42	-0.20	-0.03	-0.24	-0.14
Gross Margin	15.92%	15.26%	16.91%	18.00%	16.81%
Operating Margin	3.96%	2.60%	3.99%	5.83%	4.11%
Profit Margin	1.52%	0.15%	2.61%	3.89%	2.25%
Free Cash Flow Margin	-4.71%	-2.29%	-0.31%	-2.48%	-1.74%
EBITDA	14.21	10.68	13.6	17.97	12.08
EBITDA Margin	6.67%	5.20%	6.48%	7.77%	6.45%
D&A For EBITDA	5.76	5.33	5.22	4.5	4.37
EBIT	8.45	5.35	8.38	13.47	7.7
EBIT Margin	3.96%	2.60%	3.99%	5.83%	4.11%
Effective Tax Rate	21.16%	71.43%	11.02%	15.73%	15.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.